LeonaBio, Inc. Other Nonoperating Income (Expense)
LeonaBio, Inc. (LONA) reported Other Nonoperating Income (Expense) of $446.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-14
- LeonaBio, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $446.00K, a 37.23% increase year-over-year.
- LeonaBio, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $586.00K, a 49.11% increase year-over-year.
- LeonaBio, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $255.00K, a 54.71% decline year-over-year.
- LeonaBio, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $263.00K, a 70.11% decline year-over-year.
- LeonaBio, Inc. other nonoperating income (expense) for fiscal 2025 was $1.24M, a 68.80% decline from fiscal 2024.
- LeonaBio, Inc. other nonoperating income (expense) for fiscal 2024 was $3.96M, a 48.12% decline from fiscal 2023.
- LeonaBio, Inc. other nonoperating income (expense) for fiscal 2023 was $7.64M, a 137.47% increase from fiscal 2022.
- LeonaBio, Inc. other nonoperating income (expense) for fiscal 2022 was $3.22M, a 862.87% increase from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $446.00K 10-Q · filed 2026-08-14 | $1.03M 10-Q · filed 2026-08-14 | $1.29M derived: sum of 3 quarters · filed 2026-08-14 | $1.55M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $586.00K 10-Q · filed 2026-05-07 | $841.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.10M derived: sum of 3 quarters · filed 2026-05-07 | $1.43M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $518.00K derived: sum of 2 quarters · filed 2026-03-31 | $843.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.24M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $263.00K 10-Q · filed 2025-11-06 | $588.00K derived: sum of 2 quarters · filed 2026-08-14 | $981.00K 10-Q · filed 2025-11-06 | $1.54M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $325.00K 10-Q · filed 2026-08-14 | $718.00K 10-Q · filed 2026-08-14 | $1.28M derived: sum of 3 quarters · filed 2026-08-14 | $2.16M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $393.00K 10-Q · filed 2026-05-07 | $956.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.84M derived: sum of 3 quarters · filed 2026-05-07 | $3.00M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.44M derived: sum of 2 quarters · filed 2026-03-31 | $2.61M derived: sum of 3 quarters · filed 2026-03-31 | $3.96M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $880.00K 10-Q · filed 2025-11-06 | $2.05M derived: sum of 2 quarters · filed 2025-11-06 | $3.40M 10-Q · filed 2025-11-06 | $5.13M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $1.17M 10-Q · filed 2025-08-07 | $2.52M 10-Q · filed 2025-08-07 | $4.25M derived: sum of 3 quarters · filed 2025-08-07 | $6.32M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $1.35M 10-Q · filed 2025-05-09 | $3.08M derived: sum of 2 quarters · filed 2025-05-09 | $5.15M derived: sum of 3 quarters · filed 2025-05-09 | $7.19M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.80M derived: sum of 2 quarters · filed 2025-02-27 | $5.84M derived: sum of 3 quarters · filed 2025-02-27 | $7.64M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $2.07M 10-Q · filed 2024-11-07 | $4.12M derived: sum of 2 quarters · filed 2024-11-07 | $5.91M 10-Q · filed 2024-11-07 | $7.47M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $2.04M 10-Q · filed 2024-08-01 | $3.84M 10-Q · filed 2024-08-01 | $5.40M derived: sum of 3 quarters · filed 2024-08-01 | $6.39M derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $1.79M 10-Q · filed 2024-05-15 | $3.36M derived: sum of 2 quarters · filed 2024-05-15 | $4.34M derived: sum of 3 quarters · filed 2024-05-15 | $4.84M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.55M derived: sum of 2 quarters · filed 2024-02-22 | $3.04M derived: sum of 3 quarters · filed 2024-02-22 | $3.22M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $985.00K 10-Q · filed 2023-11-09 | $1.48M derived: sum of 2 quarters · filed 2023-11-09 | $1.65M 10-Q · filed 2023-11-09 | $1.75M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $493.00K 10-Q · filed 2023-08-10 | $666.00K 10-Q · filed 2023-08-10 | $769.00K derived: sum of 3 quarters · filed 2023-08-10 | $842.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $173.00K 10-Q · filed 2023-05-11 | $276.00K derived: sum of 2 quarters · filed 2023-05-11 | $349.00K derived: sum of 3 quarters · filed 2023-05-11 | $423.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $176.00K derived: sum of 2 quarters · filed 2023-03-23 | $250.00K derived: sum of 3 quarters · filed 2023-03-23 | $334.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $73.00K 10-Q · filed 2022-11-10 | $147.00K derived: sum of 2 quarters · filed 2022-11-10 | $231.00K 10-Q · filed 2022-11-10 | $309.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $74.00K 10-Q · filed 2022-08-15 | $158.00K 10-Q · filed 2022-08-15 | $236.00K derived: sum of 3 quarters · filed 2022-08-15 | -$823.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $84.00K 10-Q · filed 2022-05-12 | $162.00K derived: sum of 2 quarters · filed 2022-05-12 | -$897.00K derived: sum of 3 quarters · filed 2022-05-12 | -$637.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$981.00K derived: sum of 2 quarters · filed 2022-03-28 | -$721.00K derived: sum of 3 quarters · filed 2022-03-28 | -$1.28M 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$1.06M 10-Q · filed 2021-11-10 | -$799.00K derived: sum of 2 quarters · filed 2021-11-10 | -$1.36M 10-Q · filed 2021-11-10 | -$1.34M 10-Q · filed 2020-11-12 | -$1.97M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $260.00K 10-Q · filed 2021-08-16 | -$300.00K 10-Q · filed 2021-08-16 | -$911.00K derived: sum of 3 quarters · filed 2021-08-16 | -$906.00K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$560.00K 10-Q · filed 2021-05-13 | -$1.17M derived: sum of 2 quarters · filed 2021-05-13 | -$1.17M derived: sum of 3 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$606.00K derived: sum of 2 quarters · filed 2021-03-25 | -$466.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-12 | $145.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |